Skip to main content
. 2017 Dec 12;7(1):62–65. doi: 10.1007/s13730-017-0292-z

Table 1.

Main causes of rhabdomyolysis

Muscle injury or extreme exertion Trauma, crush syndrome, prolonged hours without changing position, physical torture, hypothermia, hyperthermia, seizures, delirium tremens, overexertion, compromise of major vessels leading to muscle ischemia (surgery, compartment syndrome), electric shock (e.g. from cardioversion, lightning, high-voltage electrical injury)
Toxic exposures and substances of abuse Alcohol, cocaine, amphetamines, lysergic acid diethylamide, heroin, methadone, phencyclidine, isopropyl alcohol, ethylene glycol, toluene, quail that feed on hemlock, buffalo fish, mushrooms, pesticides, heavy metals, snake or insect bites, wasp stings
Medications Antipsychotic medications that may trigger the neuroleptic malignant syndrome: (e.g. clozapine), tricyclic antidepressants, benzodiazepines, barbiturates, antihistamines (e.g. diphenhydramine), anti-retrovirals (tenofovir, raltegravir), interferon alpha, pentamidine, amphotericin B, azathioprine, penicillamine, colchicine, quinidine, terbutaline, theophylline, daptomycin, levofloxacin, ofloxacin, succinylcholine, strychnine, vasopressin, abuse of laxatives or diuretics (e.g. thiazides), paracetamol or salicylate overdose, HMG-CoA reductase inhibitors in individuals with important risk factors or in association to other medications
Metabolic and electrolyte disturbances Hypokalemia, hypophosphatemia, hypo-/hypernatremia, hypocalcemia, diabetic ketoacidosis, hyperosmolar states, infection (e.g. infectious mononucleosis, tetanus, legionnaire’s disease, coxsackievirus, malaria, HIV), inherited or acquired renal tubular dysfunction
Endocrine disease Diabetes, thyroid dysfunction, primary hyperaldosteronism, primary adrenal insufficiency, central diabetes insipidus, postpartum hypernatremia, pituitary dysfunction
Autoimmune disease Polymyositis, dermatomyositis
Inherited metabolic myopathy Disorders of glycogen metabolism e.g. phosphorylase deficiency, McArdle disease
Disorders of fatty acid oxidation: e.g. carnitine palmitoyl-transferase II deficiency
Mitochondrial disorders: e.g. coenzyme Q10 deficiency
Structural myopathies: dystrophinopathy, limb-girdle muscular dystrophy 2I, dysferlinopathy, anoctamin-5 myopathy, sarcoglycanopathy, fascioscapulohumeral muscular dystrophy
Channelopathies: RYR1 gene mutations, SCN4A gene mutation
Lipin-1 gene mutations
Adenosine monophosphate deaminase deficiency
Other conditions Sickle-cell disease, benign exertional rhabdomyolysis